Lung Cancer Awareness

Frequency and Outcomes of Brain Metastases in Patients With HER2-Mutant Lung Cancers
December 10, 2019
ByKevin Wright

Patients with metastatic non-small cell lung cancer who harbor HER2-mutations may develop brain metastases more frequently during treatment.

FDA Approves Frontline Atezolizumab Plus Chemo for Metastatic Non-Squamous NSCLC
December 04, 2019
ByKristie L. Kahl

The FDA approved atezolizumab in combination with chemotherapy for the first-line treatment of adults with metastatic non-squamous non-small cell lung cancer with no EGFR or ALK genomic tumor aberrations.

Phase III ALTA-1L Trial Shows Promise for Patients with Non-Small Cell Lung Cancer
November 26, 2019
ByHannah Slater

Takeda announced that their ongoing phase III ALTA-1L trial of brigatinib reduced the risk of disease progression or death in adults with advanced ALK-positive non-small cell lung cancer.